RFK Jr. Announces Plan to Restrict Opioid-Like Kratom Product
Federal officials said a psychoactive ingredient in kratom had been [...]
F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancy
An agency-sponsored forum included critics of psychiatry who believe the [...]
Trump Administration’s N.I.H. and F.D.A. Cuts Could Curtail New Drug Development, Budget Office Says
The Trump administration’s proposed cuts to medical research and health [...]
F.D.A. Panelists Call for Removal of Warnings on Menopause Treatments
Dr. Marty Makary, the agency’s commissioner, said too many women [...]
F.D.A. Posts Collection of Letters Outlining Concerns About New Drugs
The letters, many of which were already available online, detail [...]
Top F.D.A. Official Overrode Scientists on Covid Shots
Records show that a top U.S. regulator rejected the recommendations [...]
F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’
With a Trump-driven reduction of nearly 2,000 employees, agency officials [...]
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for [...]
FDA Nominee Marty Makary to Face Grilling Over Cutbacks and Policy Shifts
Dr. Marty Makary will testify before the Senate health committee [...]
Can Marty Makary Handle the F.D.A’.s Central Dilemma?
All eyes on Dr. Marty Makary.